In Vitro Activity of Ceftolozane-Tazobactam against Enterobacter cloacae Complex Clinical Isolates with Different β-Lactam Resistance Phenotypes [PDF]
, 2018 Frédéric Robin +6 more
openalex +1 more source
In vitroactivities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistantPseudomonas aeruginosaandAcinetobacter baumannii, andStenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan [PDF]
, 2018 Shun-Chung Hsueh +5 more
openalex +1 more source
What every intensivist should know about the management of peritonitis in the intensive care unit [PDF]
, 2018 De Waele, Jan
core +2 more sources
Determination of Alternative Ceftolozane/Tazobactam (C/T) Dosing Regimens for Patients With Infections Due to Pseudomonas aeruginosa With High (C/T) MIC Values [PDF]
, 2016 Senthil Natesan +2 more
openalex +1 more source
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection – Authors' reply [PDF]
, 2015 Florian Wagenlehner +2 more
openalex +1 more source
Mechanisms of ceftolozane/tazobactam resistance in Pseudomonas aeruginosa isolates from South Korea: A diagrostic study [PDF]
Yu Mi Wi, So Yeon Kim, Kwan Soo Ko
openalex +1 more source
Cost-effectiveness of ceftolozane/tazobactam compared to meropenem in ventilator-associated pneumonia. [PDF]
Cost Eff Resour AllocBuendía JA +2 more
europepmc +1 more source
Pseudomonas aeruginosa sequence type 357 with VEB extended-spectrum β-lactamases in the UK: relatedness and resistance [PDF]
, 2018 Greenwood, Beckie +8 more
core +1 more source
Prescribing Patterns and Clinical Outcomes of Ceftolozane/Tazobactam by Renal Function and Body Mass Index: A SPECTRA Real-World Multi-Country Analysis. [PDF]
Antibiotics (Basel)Yucel E +7 more
europepmc +1 more source
2438. Ceftolozane/Tazobactam (C/T) Against Multidrug-Resistant Pseudomonas aeruginosa (MDR-Pa) Infections: Clinical Efficacy, and Baseline and Emergent Resistance [PDF]
, 2018 Ryan K. Shields +6 more
openalex +1 more source